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The Globa l Maternal and Neonatal Sepsis Initiative: a call for 
collaboration and action by 2030
Signiﬁ cant progress has been made in reducing 
maternal and neonatal mortality in the past 15 years, but 
additional improvements will require a comprehensive 
approach that targets all causes of maternal and 
newborn mortality.1 Further reduction of maternal 
and newborn deaths is a priority for achieving the 
Sustainable Development Goals and for implementing 
the UN Global Strategy for Women’s, Children’s 
and Adolescents’ Health, and is also critical for two 
strategic plans—Every Newborn: An Action Plan to End 
Preventable Deaths (ENAP) and the Strategies toward 
Ending Preventable Maternal Mortality (EPMM).1
As part of this comprehensive approach, it is 
impossible to neglect the importance of infection as 
an underlying and contributing cause of maternal and 
newborn mortality. Deaths due to infection occur mainly 
through sepsis—a potentially life-threatening condition 
caused by a dys regulated host response to infection 
and organ dysfunction.2 Infections cause about 11% of 
maternal deaths, and are also a signiﬁ cant contributor to 
many deaths attributed to other conditions.3 The risk of 
early neonatal sepsis increases in the event of maternal 
infection.4 Early neonatal sepsis causes about 8% of all 
neonatal deaths, but the proportion of late neonatal 
deaths due to sepsis is four times higher.5 Deaths from 
maternal and neonatal sepsis expose broader health 
determinants and underlying issues of quality of care 
including infrastructure constraints, inconsistent use 
of preventive measures, delayed diagnosis, and poor 
management of infection and its complications.1,6
Considering the importance of eﬀ ective prevention, 
identiﬁ cation, and management of maternal and 
neonatal sepsis in reducing maternal and newborn 
deaths, WHO and Jhpiego have launched the Global 
Maternal and Neonatal Sepsis Initiative. This initiative 
consists of a broad programme of work that will be 
delivered through a collaborative and innovative 
approach combining research, innovation, service 
delivery programming, and advocacy. Working at 
the global, national, and health-care facility levels, 
the Initiative will identify strategic opportunities to 
increase and strengthen the response to maternal and 
newborn sepsis. The panel summarises the Initiative’s 
vision, goals, priority areas of work, and objectives. 
The Initiative has received extensive support from the 
International Federation of Gynecology and Obstetrics, 
the International Confederation of Midwives, the 
International Pediatric Association, the Global Sepsis 
Alliance, and the Surviving Sepsis Campaign, in 
collaboration with the Society of Critical Care Medicine 
and the European Society of Intensive Care Medicine.
An early output of the Initiative is the new WHO 
deﬁ nition of maternal sepsis, which reads as follows: 
“Maternal sepsis is a life-threatening condition deﬁ ned 
as organ dysfunction resulting from infection during 
pregnancy, child-birth, post-abortion, or post-partum 
period”.7 The new maternal sepsis deﬁ nition was 
developed on the basis of a review of existing deﬁ nitions 
(including the 2016 Third International Consensus 
Deﬁ nitions for Sepsis and Septic Shock2) and through 
an international technical consultation. This process 
indicated that there are several deﬁ nitions currently in 
use, which aﬀ ects the identiﬁ cation of maternal sepsis 
Panel: The Global Maternal and Neonatal Sepsis 
Initiative—vision and goals
Vision
The Global Maternal and Neonatal Sepsis Initiative will 
contribute to the Sustainable Development Goals by 
developing solutions able to reduce maternal and newborn 
deaths related to sepsis. 
Goal
Accelerate the reduction of preventable maternal and 
neonatal deaths related to sepsis.
Objectives
• Raise awareness about maternal and neonatal sepsis 
among health-care providers, policy makers, and the 
public
• Assess the burden and management of maternal and 
neonatal sepsis at the global scale 
• Develop and test eﬀ ective strategies to prevent, detect, 
and successfully manage maternal and neonatal sepsis
Priority areas of work
• Strengthening health programmes
• Research, development, and evidence generation
• Innovations
• Global advocacy
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cases. Standardising the deﬁ nition and bringing it in line 
with the current understanding of sepsis in the adult 
population was considered a mandatory step to improve 
the assessment of the burden of maternal sepsis. 
This year, the Initiative will launch a maternal and 
neonatal sepsis global mobilisation and awareness 
campaign, which will culminate in the week of 
Sept 13, 2017, with the Global Maternal Sepsis 
Study. During that week, a massive coordinated data 
collection eﬀ ort will take place to assess the burden 
and current management of maternal and neonatal 
sepsis in hundreds of health facilities in approximately 
50 countries around the world. The new maternal 
sepsis deﬁ nition and potential identiﬁ cation criteria 
will be tested and validated in this large global study. 
That eﬀ ort will be followed by the implementation of 
other speciﬁ c projects and programmes targeting the 
prevention and successful management of maternal 
and newborn sepsis. 
We invite health-care providers, health facilities, 
professional associations, researchers, and all 
concerned stakeholders around the world to join our 
eﬀ orts. We aim to establish a worldwide coalition of 
organisations, entities, health facilities, and other 
stakeholders committed to reducing the burden of 
maternal and newborn sepsis. As we move forwards 
together, implementation of eﬀ ective strategies for 
the prevention and management of maternal and 
neonatal sepsis will be scaled up and evaluated through 
the network of collaborating facilities and partners. 
Lessons learned will be used to inform governments 
and organisations in order to ensure that maternal 
and neonatal sepsis will no longer be an obstacle to 
achieving the Sustainable Development Goals by 2030.
The Global Maternal and Neonatal Sepsis Initiative 
Working Group
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of 
Research, Development and Research Training in Human  
Reproduction, Department of Reproductive Health and Research, 
WHO, 1211 Geneva 27, Switzerland
bonetm@who.int
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